Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05565586 · ClinicalTrials.gov registry record · NA

Impact of High Dietary Fiber on Microbiome and Vaccine Responses

A NA study of Influenza, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
31
Enrollment target
1
Study location

NCT05565586 is a NA study of Influenza that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 31 participants, below the 36,804-participant average among 156 other Influenza trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05565586, a NA study of Influenza, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
31 participants
Enrollment target
1
Study location

Study Summary

To learn if diet can enhance the microbes (such as bacteria and viruses) found in your gut and improve the body's immune response to the influenza (flu) vaccine.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT High-Fiber Diet (HFD)
  • DIETARY_SUPPLEMENT Prebiotic Food-Enriched Diet (PreFED)

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2022-08-23
Est. Completion 2029-01-02
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT05565586

The ClinicalTrials.gov registry entry for NCT05565586 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 36,804-participant average among 156 other Influenza trials with a reported enrollment target (100% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Influenza appearing as the primary indexed condition, and to 2 interventions - of which High-Fiber Diet (HFD) is the first listed.

NCT05565586 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05565586 about?

NCT05565586 is a clinical study titled "Impact of High Dietary Fiber on Microbiome and Vaccine Responses". To learn if diet can enhance the microbes (such as bacteria and viruses) found in your gut and improve the body's immune response to the influenza (flu) vaccine.

What is the current status of trial NCT05565586?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 31 participants. The study started on 2022-08-23. Estimated completion is 2029-01-02.

What conditions does trial NCT05565586 study?

This clinical trial studies the following conditions: Influenza.

What interventions are being tested in trial NCT05565586?

The interventions under investigation include: High-Fiber Diet (HFD) (DIETARY_SUPPLEMENT), Prebiotic Food-Enriched Diet (PreFED) (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05565586?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05565586 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Influenza

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.